Human uterine and ovarian expression of growth hormone-releasing hormone messenger RNA in benign and malignant gynecologic conditions

被引:41
作者
Khorram, O [1 ]
Garthwaite, M [1 ]
Grosen, E [1 ]
Golos, T [1 ]
机构
[1] Univ Wisconsin, Dept Obstet & Gynecol, Madison, WI 53706 USA
关键词
growth hormone-releasing hormone; endometrium; ovary; endometriosis; endometrial cancer; ovarian cancer;
D O I
10.1016/S0015-0282(00)01658-7
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To determine uterine and ovarian expression of growth hormone-releasing hormone (GHRH) messenger RNA (mRNA) in benign and pathologic gynecologic states. Design: Case-control study. Setting: Tertiary-care academic department. Patient(s): Women undergoing hysterectomy for benign or malignant gynecologic conditions. Intervention(s): Ovarian and uterine tissue was obtained for measurement of GHRH mRNA levels by reverse transcription polymerase chain reaction. Main Outcome Measure(s): Levels of GHRH mRNA in normal tissues were compared with those in tissues with pathologic abnormalities. Result(s): Growth hormone-releasing hormone mRNA was detectable in the ovary, endometrium, myometrium, fallopian tubes, and placenta. Levels of GHRH mRNA were significantly increased in secretory endometrium compared with proliferative endometrium. Hormone replacement therapy did not affect endometrial GHRH mRNA levels. Uterine myomas expressed similar levels of GHRH mRNA as normal myometrium. No changes in endometrial GHRH mRNA were detected in endometrial cancers compared with normal endometrium or myometrium obtained from the same patient; however, these levels were higher than those in noncancerous myometrial tissue obtained from other patients with benign gynecologic disease. In ovarian tissue, no differences in GHRH mRNA were found between premenopausal and postmenopausal women. Ovarian GHRH mRNA was significantly decreased in endometriotic cysts, whereas significantly greater GHRH expression occurred in ovarian cancer compared with normal ovarian tissue. Conclusion(s): Endometrial and ovarian GHRH gene transcription are altered in selective physiologic and pathologic states and are influenced by such factors as ovarian hormones, Because it is a growth factor, GHRH may promote endometrial proliferation and may be involved in the pathogenesis of ovarian and endometrial cancer and endometriosis. (C) 2001 by American Society for Reproductive Medicine.
引用
收藏
页码:174 / 179
页数:6
相关论文
共 20 条
[1]   GROWTH HORMONE-RELEASING FACTOR STIMULATES MEIOTIC MATURATION IN FOLLICLE-ENCLOSED AND CUMULUS-ENCLOSED RAT OOCYTE [J].
APA, R ;
LANZONE, A ;
MICELI, F ;
MASTRANDREA, M ;
MACCHIONE, E ;
CARUSO, A ;
MANCUSO, S ;
CANIPARI, R .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1995, 112 (02) :195-201
[2]   IMMUNOHISTOLOGICAL LOCALIZATION OF GROWTH HORMONE-RELEASING HORMONE IN HUMAN-TUMORS [J].
ASA, SL ;
KOVACS, K ;
THORNER, MO ;
LEONG, DA ;
RIVIER, J ;
VALE, W .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 60 (03) :423-427
[3]   Somatostatin and growth hormone-releasing hormone in normal and tumoral human breast tissue: Endogenous content, in vitro pulsatile release, and regulation [J].
Benlot, C ;
Levy, L ;
Fontanaud, P ;
Roche, A ;
Rouannet, P ;
Joubert, D .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (02) :690-696
[4]  
BREGNATO A, 1992, ENDOCRINOLOGY, V130, P1097
[5]  
CHRISTOFIDES ND, 1984, J CLIN ENDOCR METAB, V59, P747, DOI 10.1210/jcem-59-4-747
[6]   GROWTH HORMONE-RELEASING HORMONE IS PRODUCED BY RAT LEYDIG-CELL IN CULTURE AND ACTS AS A POSITIVE REGULATOR OF LEYDIG-CELL FUNCTION [J].
CIAMPANI, T ;
FABBRI, A ;
ISIDORI, A ;
DUFAU, ML .
ENDOCRINOLOGY, 1992, 131 (06) :2785-2792
[7]   LOW-DOSE GROWTH HORMONE-RELEASING FACTOR MAY ENHANCE FOLLICULOGENESIS IN REGULARLY MENSTRUATING WOMEN - A PRELIMINARY-STUDY [J].
DUFFY, DM ;
LINDHEIM, SR ;
VIJOD, MA ;
CHANG, L ;
NAKAMURA, RM ;
LOBO, RA .
FERTILITY AND STERILITY, 1995, 63 (04) :756-760
[8]   GROWTH HORMONE-RELEASING HORMONE IN TESTICULAR INTERSTITIAL AND GERM-CELLS - POTENTIAL PARACRINE MODULATION OF FOLLICLE-STIMULATING-HORMONE ACTION ON SERTOLI-CELL FUNCTION [J].
FABBRI, A ;
CIOCCA, DR ;
CIAMPANI, T ;
WANG, J ;
DUFAU, ML .
ENDOCRINOLOGY, 1995, 136 (05) :2303-2308
[9]   GROWTH-HORMONE RELEASING-FACTOR FROM A HUMAN PANCREATIC TUMOR THAT CAUSED ACROMEGALY [J].
GUILLEMIN, R ;
BRAZEAU, P ;
BOHLEN, P ;
ESCH, F ;
LING, N ;
WEHRENBERG, WB .
SCIENCE, 1982, 218 (4572) :585-587
[10]   Does growth hormone-releasing factor assist follicular development in poor responder patients undergoing ovarian stimulation for in-vitro fertilization? [J].
Howles, CM ;
Loumaye, E ;
Germond, M ;
Yates, R ;
Brinsden, P ;
Healy, D ;
Bonaventura, LM ;
Strowitzki, T .
HUMAN REPRODUCTION, 1999, 14 (08) :1939-1943